Opponents of the bill included pharmaceutical and biotechnology companies, such as Johnson & Johnson and Amgen Inc., who say it weakens patent protection by reducing infringement penalties and permitting post-approval challenges to patents. ...
The Senate Judiciary Committee approved a similar version of the bill in July and it awaits a vote in the full Senate.
That bill includes a provision that would protect banks from damage awards in patent infringement cases involving electronic check-clearing technologies, such as check-imaging systems.
Banks have paid millions of dollars to settle allegations of infringement of such technologies, the American Bankers Association said in July.
"
No comments:
Post a Comment